{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:34:14Z","timestamp":1793136854922,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.healun.2024.02.1458","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T06:12:45Z","timestamp":1709100765000},"page":"931-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Vasoplegic syndrome during heart transplantation: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-8436","authenticated-orcid":false,"given":"Nicolas","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj H.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Essandoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam A.","family":"Dalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-097X","authenticated-orcid":false,"given":"Asishana","family":"Osho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara R.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.02.1458_bib1","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1053\/j.jvca.2019.12.013","article-title":"Vasoplegia during cardiopulmonary bypass: current literature and rescue therapy options","volume":"34","author":"Ortoleva","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cardfail.2022.02.008","article-title":"Vasodilatory shock after heart transplantation: the enigma continues","volume":"28","author":"Parikh","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2024.02.1458_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2024.02.1458_bib4","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2009"},{"key":"10.1016\/j.healun.2024.02.1458_bib5","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jtcvs.2016.07.077","article-title":"Changes in United States heart allocation: a community energized to improve policy","volume":"152","author":"Rogers","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: current concepts and management","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib7","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.89.5.2035","article-title":"Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans","volume":"89","author":"Stamler","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.02.1458_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.02.1458_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.healun.2024.02.1458_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008377","article-title":"Determinants and outcomes of vasoplegia following left ventricular assist device implantation","volume":"7","author":"Tecson","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.02.1458_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.healun.2024.02.1458_bib12","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.healun.2024.02.1458_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.healun.2024.02.1458_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2017.09.039","article-title":"Characterizing predictors and severity of vasoplegia syndrome after heart transplantation","volume":"105","author":"Chan","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12871-021-01455-x","article-title":"Early postoperative hemodynamic instability after heart transplantation - incidence and metabolic indicators","volume":"21","author":"K\u0119dziora","year":"2021","journal-title":"BMC Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib16","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1053\/j.jvca.2019.03.054","article-title":"Use of angiotensin II for vasoplegic shock in a combined heart and liver transplant recipient with systolic anterior motion physiology","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib17","doi-asserted-by":"crossref","first-page":"343.e5","DOI":"10.1016\/j.cjca.2017.12.004","article-title":"Profound vasoplegia during sacubitril\/valsartan treatment after heart transplantation","volume":"34","author":"Almufleh","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2024.02.1458_bib18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.jvca.2007.11.003","article-title":"Concomitant pulmonary hypertension and vasoplegia syndrome after heart transplant: a challenging picture","volume":"22","author":"Bozzetti","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib19","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1053\/j.jvca.2020.07.087","article-title":"Angiotensin II for critically Ill patients with shock after heart transplant","volume":"35","author":"Cutler","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib20","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jtcvs.2012.07.030","article-title":"The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature","volume":"144","author":"Grubb","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1053-0770(98)90017-9","article-title":"Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration","volume":"12","author":"Mets","year":"1998","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14797\/mdcvj.576","article-title":"Angiotensin II: a multimodal approach to vasoplegia in a cardiac setting","volume":"17","author":"Sovic","year":"2021","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.healun.2024.02.1458_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.jvca.2015.12.013","article-title":"Use of oral droxidopa to improve arterial pressure and reduce vasoactive drug requirements during persistent vasoplegic syndrome after cardiac transplantation","volume":"30","author":"Zundel","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib25","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.21037\/jtd.2020.03.53","article-title":"Vasoplegia following heart transplantation and left ventricular assist device explant is not associated with inferior outcomes","volume":"12","author":"Ali","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2024.02.1458_bib26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1053-2498(99)00038-8","article-title":"Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation","volume":"18","author":"Argenziano","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013108","article-title":"Predictors and clinical outcomes of vasoplegia in patients bridged to heart transplantation with continuous-flow left ventricular assist devices","volume":"8","author":"Asleh","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.02.1458_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cardfail.2021.11.020","article-title":"Vasoplegia following orthotopic heart transplantation: prevalence, predictors and clinical outcomes","volume":"28","author":"Batchelor","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2024.02.1458_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation","volume":"25","author":"Byrne","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/icvts\/ivx081","article-title":"Vasoplegia after heart transplantation: outcomes at 1 year","volume":"25","author":"Chan","year":"2017","journal-title":"Inter Cardiovasc Thorac Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1053-2498(01)00299-6","article-title":"Hypotension, acidosis, and vasodilatation syndrome post-heart transplant: prognostic variables and outcomes","volume":"20","author":"Chemmalakuzhy","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13994","article-title":"Incidence of vasoplegic syndrome after cardiac transplantation in patients treated with sacubitril\/valsartan","volume":"34","author":"Dom\u00ednguez","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib33","article-title":"ARNI pre-operative use and vasoplegic syndrome in patients undergoing heart transplantation or left ventricular assist device surgery","volume":"10","author":"Haider","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.healun.2024.02.1458_bib34","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0041-1345(03)00730-9","article-title":"Hypotension, acidosis and vasodilation syndrome after heart transplant: incidence, risk factors, and prognosis","volume":"35","author":"Paniagua","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2024.02.1458_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2011.10.010","article-title":"Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era","volume":"31","author":"Patarroyo","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib36","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.amjcard.2018.08.035","article-title":"Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation","volume":"122","author":"Raza","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2024.02.1458_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MAT.0000000000000623","article-title":"Incidence and impact of on-cardiopulmonary bypass vasoplegia during heart transplantation","volume":"64","author":"Truby","year":"2018","journal-title":"Asaio J"},{"key":"10.1016\/j.healun.2024.02.1458_bib38","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/j.healun.2019.01.514","article-title":"Elevated pre-transplant neutrophil to lymphocyte ratio is associated with increased vasoplegia syndrome in cardiac transplantation","volume":"38","author":"Ahmed","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib39","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1016\/j.healun.2019.01.995","article-title":"Risk factors and early outcomes of vasoplegia syndrome (VS) after heart transplantation in CF-LVAD patients","volume":"38","author":"Chinnadurai","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib40","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.healun.2023.02.185","article-title":"Incidence and predictors of vasoplegia after heart transplantation: results from the international PGD consortium","volume":"42","author":"Han","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib41","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/j.healun.2022.01.1692","article-title":"ACEi use in select patients awaiting heart transplant may be a risk factor for the development of primary graft dysfunction and vasoplegia","volume":"41","author":"Kim","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib42","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.healun.2022.01.235","article-title":"Is sacubitril\/valsartan a risk factor for vasoplegia\/primary graft dysfunction after heart transplantation?","volume":"41","author":"Kittleson","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib43","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1016\/j.healun.2019.01.1023","article-title":"Incidence of vasoplegia in post-heart transplant patients treated with phosphodiesterase-5 inhibitors secondary to right ventricular dysfunction post-left ventricular assist device","volume":"38","author":"Meloche","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib44","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/j.healun.2022.01.1485","article-title":"Impact of vasoplegic syndrome on early clinical outcome after orthotopic heart transplantation","volume":"41","author":"Volgmann","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib45","first-page":"129","article-title":"Vasoplegia syndrome is not associated with higher mortality rate after heart transplant","volume":"28","author":"Kao","year":"2012","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.healun.2024.02.1458_bib46","first-page":"363","article-title":"Serotonin syndrome following methylene blue administration for vasoplegic syndrome in heart and lung transplantation\u2013a case series","volume":"4","author":"Arias-Morales","year":"2016","journal-title":"Int J Anesth Res"},{"key":"10.1016\/j.healun.2024.02.1458_bib47","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1016\/j.healun.2016.01.464","article-title":"Vasoplegia after heart transplantation: unraveling the enigma","volume":"35","author":"Esmailian","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.02.1458_bib48","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.athoracsur.2009.06.095","article-title":"Activation of endothelial and coagulation systems in left ventricular assist device recipients","volume":"88","author":"John","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamacardio.2020.0667","article-title":"Trends in mechanical support use as a bridge to adult heart transplant under new allocation rules","volume":"5","author":"Hanff","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.healun.2024.02.1458_bib50","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/CIRCULATIONAHA.120.048844","article-title":"Changes in type of temporary mechanical support device use under the new heart allocation policy","volume":"142","author":"Golbus","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.02.1458_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.09-0252","article-title":"Complications of massive transfusion","volume":"137","author":"Sihler","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.02.1458_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.hlc.2019.02.008","article-title":"Risk Factors and Outcomes in Redo Coronary Artery Bypass Grafting","volume":"29","author":"Gallo","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.healun.2024.02.1458_bib53","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1210\/jc.2003-030039","article-title":"Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy","volume":"88","author":"Taddei","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.healun.2024.02.1458_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib55","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2024.02.1458_bib56","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/03913988211007865","article-title":"Hemodynamic impact of molecular adsorbent recirculating system in refractory vasoplegic shock due to calcium channel blocker poisoning","volume":"44","author":"Beyls","year":"2021","journal-title":"Int J Artif Organs"},{"issue":"Suppl 3","key":"10.1016\/j.healun.2024.02.1458_bib57","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF00051613","article-title":"Pharmacological aspects of calcium channel blockers","volume":"10","author":"Scholz","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.healun.2024.02.1458_bib58","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.amjcard.2008.12.028","article-title":"Usefulness of isosorbide dinitrate and hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure","volume":"103","author":"Mullens","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2024.02.1458_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1378\/chest.75.1.2","article-title":"Duration of action of isosorbide dinitrate","volume":"75","author":"Russell","year":"1979","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.02.1458_bib60","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/17425255.2022.2129005","article-title":"A review on the clinical pharmacokinetics of hydralazine","volume":"18","author":"Shahzad Qamar","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.healun.2024.02.1458_bib61","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.jvca.2023.05.001","article-title":"Hydroxocobalamin in refractory vasodilatory shock: more questions than answers","volume":"37","author":"Kumar","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2024.02.1458_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.jvca.2023.08.134","article-title":"Hydroxocobalamin vs methylene blue: still unanswered and needing a change in approach","volume":"38","author":"Kumar","year":"2024","journal-title":"Cardiothorac Vasc Anesth"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824014980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824014980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T16:34:28Z","timestamp":1715445268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824014980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1053249824014980"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.02.1458","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoplegic syndrome during heart transplantation: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.02.1458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}